AbbVie Inc. (NYSE:ABBV)

investor research

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

Stocks were firm on Tuesday morning during a shortened week that actually will be full of economic reports. 24/7 Wall St. reviews dozens of analyst research reports each morning of ...
Read Full Story »
health care

Analyst Cancer and Biotech Stock Picks From ASCO

As the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical data. The biggest ...
Read Full Story »
down market

Why You Buy Big Pharma If the Market Crashes

Defensive sectors have done well this year, with utilities leading the way. One of the reasons is that despite the market hitting new all-time highs, there remains a wall of ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: eBay, GNC, Groupon, Hecla, J.C. Penney, Whole Foods and More

Stocks are trying to recover on Wednesday after pulling back close to 2% from the recent highs. Investors still want bull market upside, but they want to avoid the blowups ...
Read Full Story »
Target logo

Why Target Shares Fell Rather Than Rose on CEO Firing

Shares of Target Corp. (NYSE: TGT) are taking a hit of around 3% Monday morning following the resignation/firing of Chairman/President/CEO Gregg Steinhafel. The now-former CEO is being replaced temporarily by ...
Read Full Story »
Merger

Baxter Split-Up, a Page From Abbott’s Playbook

Baxter International Inc. (NYSE: BAX) is taking an activist investor role of its own. The health care company has announced that it is splitting itself into two separate companies, in ...
Read Full Story »
145922793

Jefferies’ Cheapest Health Care Stocks to Buy

With the beating the market took Thursday, many investors are starting to get a little worried that a major correction might be right around the corner. With the first quarter ...
Read Full Story »
health care

Merrill Lynch’s Top Health Care Stocks to Buy Now

Very quietly, while momentum stocks zoom up and down, one sector has made an almost stealth like move and is leading the S&P 500 so far this year. With the ...
Read Full Story »
investor research

Five Quantitative Analyst Stocks With Limited Emerging Markets Exposure

With U.S. interest rates set to rise, concerns of a slowdown in the Chinese economy and the devaluation of several emerging market (EM) currencies, those markets are facing a rocky ...
Read Full Story »
Wall St Bull statue

Many Key Changes to Goldman Sachs Conviction Buy List for 2014

2014 is upon us, and that means that investors have started positioning their portfolios for the year ahead. 24/7 Wall St. reviews many analyst calls each day in order to ...
Read Full Story »
goldman sachs

Goldman Sachs Makes Major Conviction Buy List Changes for 2014

It is that time of year when investors start positioning their portfolios for the year ahead. 24/7 Wall St. reviews vast numbers of research reports looking for the best stocks ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

Stocks have finally shown that they can drop again, and Tuesday is looking a tad soft so far. After gains of well over 20% in the DJIA and S&P 500 ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, BBVA, Kors, PotBelly and More

We are in the thick of earnings season, a deal was made in D.C. and stocks are challenging new all-time highs almost daily. So how do investors know which stocks ...
Read Full Story »
IPO

New IPO ETF Certain to Gain Traction, More IPO ETF Competition

The saying is that if there is a trading strategy, then there is an ETF strategy for that as well. Now the markets are getting a new exchange-traded fund strategy ...
Read Full Story »
Pills

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

The drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week's government shutdown and impending debt ceiling weighed heavily on biotech stocks. Credit ...
Read Full Story »